Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2

P. Van Damme, J. H. Veldink, Marka Van Blitterswijk, A. Corveleyn, P. W J Van Vught, V. Thijs, B. Dubois, G. Matthijs, L. H. Van Den Berg, W. Robberecht

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons that results in progressive muscle weakness and limits survival to 2-5 years after disease onset. Intermediate CAG repeat expansions in ataxin 2 (ATXN2), the causative gene of spinocerebellar ataxia type 2 (SCA2), have been implicated in sporadic ALS. We studied ATXN2 in a large cohort of patients with sporadic and familial ALS. Methods: We determined ATXN2 CAG repeat size in 1,948 sporadic and familial ALS cases and 2,002 controls from Belgium and the Netherlands. Results: In controls, the maximal ATXN2 repeat size was 31. In sporadic ALS, a significant amount of longer repeat sizes (32, range 32-39) were encountered (in 0.5% or 10/1,845 ALS cases, vs 0% in controls, p = 0.0006). Receiver operating characteristic analysis showed that a cutoff of 29 appeared optimal to discriminate ALS from control (p = 0.036, odds ratio [OR] 1.92, 95% confidence interval [CI] 1.04-3.64). A meta-analysis with the previously published results from the United States showed that the association between a repeat length of 29 and ALS became stronger (p < 0.0001, OR 2.93, 95% CI 1.73-4.98). In unexplained familial ALS, we found an intermediate repeat expansion of 31 and a homozygous repeat expansion of 33 each in 1.1% of families. The phenotype of patients with ALS with expanded repeat sizes ranged from rapidly progressive typical ALS to slowly progressive ALS with reduced sensory nerve action potentials. Conclusion: Our data reveal a novel genetic overlap between ALS and SCA2.

Original languageEnglish (US)
Pages (from-to)2066-2072
Number of pages7
JournalNeurology
Volume76
Issue number24
DOIs
StatePublished - Jun 14 2011
Externally publishedYes

Fingerprint

Spinocerebellar Ataxias
Amyotrophic Lateral Sclerosis
Odds Ratio
Confidence Intervals
Amyotrophic lateral sclerosis 1
Ataxin-2
Belgium
Muscle Weakness
Motor Neurons
ROC Curve
Neurodegenerative Diseases
Netherlands
Action Potentials
Meta-Analysis
Phenotype
Survival

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Van Damme, P., Veldink, J. H., Van Blitterswijk, M., Corveleyn, A., Van Vught, P. W. J., Thijs, V., ... Robberecht, W. (2011). Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology, 76(24), 2066-2072. https://doi.org/10.1212/WNL.0b013e31821f445b

Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. / Van Damme, P.; Veldink, J. H.; Van Blitterswijk, Marka; Corveleyn, A.; Van Vught, P. W J; Thijs, V.; Dubois, B.; Matthijs, G.; Van Den Berg, L. H.; Robberecht, W.

In: Neurology, Vol. 76, No. 24, 14.06.2011, p. 2066-2072.

Research output: Contribution to journalArticle

Van Damme, P, Veldink, JH, Van Blitterswijk, M, Corveleyn, A, Van Vught, PWJ, Thijs, V, Dubois, B, Matthijs, G, Van Den Berg, LH & Robberecht, W 2011, 'Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2', Neurology, vol. 76, no. 24, pp. 2066-2072. https://doi.org/10.1212/WNL.0b013e31821f445b
Van Damme, P. ; Veldink, J. H. ; Van Blitterswijk, Marka ; Corveleyn, A. ; Van Vught, P. W J ; Thijs, V. ; Dubois, B. ; Matthijs, G. ; Van Den Berg, L. H. ; Robberecht, W. / Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. In: Neurology. 2011 ; Vol. 76, No. 24. pp. 2066-2072.
@article{42001f010870451da30acd45b16b623e,
title = "Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2",
abstract = "Objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons that results in progressive muscle weakness and limits survival to 2-5 years after disease onset. Intermediate CAG repeat expansions in ataxin 2 (ATXN2), the causative gene of spinocerebellar ataxia type 2 (SCA2), have been implicated in sporadic ALS. We studied ATXN2 in a large cohort of patients with sporadic and familial ALS. Methods: We determined ATXN2 CAG repeat size in 1,948 sporadic and familial ALS cases and 2,002 controls from Belgium and the Netherlands. Results: In controls, the maximal ATXN2 repeat size was 31. In sporadic ALS, a significant amount of longer repeat sizes (32, range 32-39) were encountered (in 0.5{\%} or 10/1,845 ALS cases, vs 0{\%} in controls, p = 0.0006). Receiver operating characteristic analysis showed that a cutoff of 29 appeared optimal to discriminate ALS from control (p = 0.036, odds ratio [OR] 1.92, 95{\%} confidence interval [CI] 1.04-3.64). A meta-analysis with the previously published results from the United States showed that the association between a repeat length of 29 and ALS became stronger (p < 0.0001, OR 2.93, 95{\%} CI 1.73-4.98). In unexplained familial ALS, we found an intermediate repeat expansion of 31 and a homozygous repeat expansion of 33 each in 1.1{\%} of families. The phenotype of patients with ALS with expanded repeat sizes ranged from rapidly progressive typical ALS to slowly progressive ALS with reduced sensory nerve action potentials. Conclusion: Our data reveal a novel genetic overlap between ALS and SCA2.",
author = "{Van Damme}, P. and Veldink, {J. H.} and {Van Blitterswijk}, Marka and A. Corveleyn and {Van Vught}, {P. W J} and V. Thijs and B. Dubois and G. Matthijs and {Van Den Berg}, {L. H.} and W. Robberecht",
year = "2011",
month = "6",
day = "14",
doi = "10.1212/WNL.0b013e31821f445b",
language = "English (US)",
volume = "76",
pages = "2066--2072",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "24",

}

TY - JOUR

T1 - Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2

AU - Van Damme, P.

AU - Veldink, J. H.

AU - Van Blitterswijk, Marka

AU - Corveleyn, A.

AU - Van Vught, P. W J

AU - Thijs, V.

AU - Dubois, B.

AU - Matthijs, G.

AU - Van Den Berg, L. H.

AU - Robberecht, W.

PY - 2011/6/14

Y1 - 2011/6/14

N2 - Objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons that results in progressive muscle weakness and limits survival to 2-5 years after disease onset. Intermediate CAG repeat expansions in ataxin 2 (ATXN2), the causative gene of spinocerebellar ataxia type 2 (SCA2), have been implicated in sporadic ALS. We studied ATXN2 in a large cohort of patients with sporadic and familial ALS. Methods: We determined ATXN2 CAG repeat size in 1,948 sporadic and familial ALS cases and 2,002 controls from Belgium and the Netherlands. Results: In controls, the maximal ATXN2 repeat size was 31. In sporadic ALS, a significant amount of longer repeat sizes (32, range 32-39) were encountered (in 0.5% or 10/1,845 ALS cases, vs 0% in controls, p = 0.0006). Receiver operating characteristic analysis showed that a cutoff of 29 appeared optimal to discriminate ALS from control (p = 0.036, odds ratio [OR] 1.92, 95% confidence interval [CI] 1.04-3.64). A meta-analysis with the previously published results from the United States showed that the association between a repeat length of 29 and ALS became stronger (p < 0.0001, OR 2.93, 95% CI 1.73-4.98). In unexplained familial ALS, we found an intermediate repeat expansion of 31 and a homozygous repeat expansion of 33 each in 1.1% of families. The phenotype of patients with ALS with expanded repeat sizes ranged from rapidly progressive typical ALS to slowly progressive ALS with reduced sensory nerve action potentials. Conclusion: Our data reveal a novel genetic overlap between ALS and SCA2.

AB - Objectives: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons that results in progressive muscle weakness and limits survival to 2-5 years after disease onset. Intermediate CAG repeat expansions in ataxin 2 (ATXN2), the causative gene of spinocerebellar ataxia type 2 (SCA2), have been implicated in sporadic ALS. We studied ATXN2 in a large cohort of patients with sporadic and familial ALS. Methods: We determined ATXN2 CAG repeat size in 1,948 sporadic and familial ALS cases and 2,002 controls from Belgium and the Netherlands. Results: In controls, the maximal ATXN2 repeat size was 31. In sporadic ALS, a significant amount of longer repeat sizes (32, range 32-39) were encountered (in 0.5% or 10/1,845 ALS cases, vs 0% in controls, p = 0.0006). Receiver operating characteristic analysis showed that a cutoff of 29 appeared optimal to discriminate ALS from control (p = 0.036, odds ratio [OR] 1.92, 95% confidence interval [CI] 1.04-3.64). A meta-analysis with the previously published results from the United States showed that the association between a repeat length of 29 and ALS became stronger (p < 0.0001, OR 2.93, 95% CI 1.73-4.98). In unexplained familial ALS, we found an intermediate repeat expansion of 31 and a homozygous repeat expansion of 33 each in 1.1% of families. The phenotype of patients with ALS with expanded repeat sizes ranged from rapidly progressive typical ALS to slowly progressive ALS with reduced sensory nerve action potentials. Conclusion: Our data reveal a novel genetic overlap between ALS and SCA2.

UR - http://www.scopus.com/inward/record.url?scp=79959653680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959653680&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31821f445b

DO - 10.1212/WNL.0b013e31821f445b

M3 - Article

C2 - 21562247

AN - SCOPUS:79959653680

VL - 76

SP - 2066

EP - 2072

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 24

ER -